It is currently Sat Jun 25, 2016 12:47 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

What is inactive ms exactly?

Hi Everyone,

As my main area of reading is now everything to do with ms, i have many times come across terms like active and non active ms.

Does anyone know what this means? Is inactive ms just ms that is "asleep" and currently silent and not causing any problems?

Is it active when demyelination is occuring?

Is the aim of dmd's to help ms to remain inactive as long as possible as well as ...
Read more : What is inactive ms exactly? | Views : 4818 | Replies : 7 | Forum : General Discussion

Progressive MS Pipeline

Upon request, here are the drugs from the pipeline that are being tested for progressive forms of MS. If I've missed anything, please let me know.

Progressive MS Treatment Pipeline - September 2011

Phase 3 Trials
- Gilenya (aka FTY720 and fingolimod) (PPMS) (Novartis)
- Masitinib (SPMS and PPMS) (aka Kinavet or AB1010) (AB Science)
- Ocrelizumab (R1594) (trial for PPMS) (Genentech, Roche, Biogen)
- Revimmune (aka high dose cyclophosphamide or cytoxan) (Accentia Biopharmaceuticals) (refractory ...
Read more : Progressive MS Pipeline | Views : 33279 | Replies : 31 | Forum : Drug Pipeline

more lucky mice (stem cells as therapy for Parkinson's)

Therapeutic Cloning Works in Mice With Parkinson's

By Alan Mozes
HealthDay Reporter
Monday, March 24, 2008; 12:00 AM

MONDAY, March 24 (HealthDay News) -- Therapeutic cloning successfully treated Parkinson's disease in mice, researchers report.

Using the process to develop dopamine-producing neurons with an identical genetic profile to each mouse being treated allowed scientists to significantly improve the neurological performance of the diseased animals, without provoking any evidence of immune system rejection.

"This is the first ...
Read more : more lucky mice (stem cells as therapy for Parkinson's) | Views : 1729 | Replies : 1 | Forum : Stem Cells


A preclinical - but looks interesting as focuses on repair ... 0&w=464753
Read more : Neuroblastin | Views : 1913 | Replies : 2 | Forum : Drug Pipeline

I'm being bad

I decided to stop taking my Rebif. Tonight will be my first missed shot. :twisted:

My neuro wanted me to go for three more months, and I've lasted two. Screw it, I have a crazy month ahead of me work-wise, I am d.o.n.e.

I packed up my auto injector and supplies and stuffed them in the very back of my closet. I truly hope to never ...
Read more : I'm being bad | Views : 3155 | Replies : 8 | Forum : Rebif

ThisIsMS Forums FAQ

I've decided to start a FAQ thread for common questions related to using the forums here at ThisIsMS. If you have a question or suggestion, then please PM me. I would be happy to hear from any of the members of the ThisIsMS community.

Read more : ThisIsMS Forums FAQ | Views : 21862 | Replies : 32 | Forum : Site Support

$15 million for MS Research on the line

The U.S. Department of Defense and its ridiculously humongous budget may actually be put to some good :)

"Now is the time to pursue MS research in the CDMRP for fiscal year 2009. This program is funded annually through the Department of Defense (DoD) appropriations bill. Last year, your efforts influenced Congress to include MS and for the first time it became one of the areas ...
Read more : $15 million for MS Research on the line | Views : 1555 | Replies : 2 | Forum : General Discussion

Opexa News

I suppose this is to be expected for a company without a retail product undergoing an expensive R & D process with its lead candidate.

Opexa Therapeutics 4Q Loss Widens
Opexa Therapeutics' 4th-Quarter Loss Widens on Higher Research and Development Costs
March 18, 2008: 09:22 AM EST

NEW YORK (Associated Press) - Biotechnology company Opexa Therapeutics Inc. said Tuesday its 2007 loss widened on higher research and development expenses.

The company lost $14.7 million, or ...
Read more : Opexa News | Views : 12542 | Replies : 61 | Forum : Tcelna (Tovaxin)


Peptide Copolymer Study Completed For Multiple Sclerosis Treatment - Disease

Written on March 21, 2008 – 11:59 pm | by admin

Peptimmune has completed its first clinical trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of PI-2301, a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.

The Phase I single ascending dose, double blind placebo controlled randomized study involved 56 healthy volunteers who received the drug in eight escalating ...
Read more : PI-2301 | Views : 1963 | Replies : 1 | Forum : Drug Pipeline

Onset of ON?

Over the past month or so I have noticed that when I close my eyes especially when I lay down at night I have excessively more spots of flashing lights. Does anyone think this is an indication that it may someday progress to ON? Are the MRTC's attacking my optic nerve? I am in the Tovaxin study and IF I was on the real thing I haven't been dosed for over 6 months if I ...
Read more : Onset of ON? | Views : 1271 | Replies : 0 | Forum : General Discussion


Login  •  Register


Total posts 232915 • Total topics 24940 • Total members 16078

Contact us | Terms of Service